Perbedaan Intan Baru Prana Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Intan Baru Prana Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 103,18 M, volume 24 jam 799,4 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Intan Baru Prana Tbk. lebih aktif diperdagangkan (799,4 rb vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IBFN | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 103,18 M | 166,01 M |
Volume | 799,4 rb | 324 rb |
Lot | 7,99 rb | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Selengkapnya di halaman IBFN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →